Pretreatment Neutrophil to Lymphocyte Ratio (NLR) Predicts Prognosis for Castration Resistant Prostate Cancer Patients Underwent Enzalutamide

INTRODUCTION: Nearly 80% of advanced prostate cancer patients respond to initial androgen deprivation therapy (ADT). However, ADT does not prevent the progression of prostate cancer over the long term, and the disease eventually progresses to castration-resistant prostate cancer (CRPC). Prior to the...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Biomed Res Int
Hoofdauteurs: Kumano, Yohei, Hasegawa, Yoriko, Kawahara, Takashi, Yasui, Masato, Miyoshi, Yasuhide, Matsubara, Nobuaki, Uemura, Hiroji
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Hindawi 2019
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6360569/
https://ncbi.nlm.nih.gov/pubmed/30800682
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/9450838
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items